191 related articles for article (PubMed ID: 29948779)
1. Octreotide Use in Neonates: A Case Series.
Zaki SA; Krishnamurthy MB; Malhotra A
Drugs R D; 2018 Sep; 18(3):191-198. PubMed ID: 29948779
[TBL] [Abstract][Full Text] [Related]
2. Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis.
Namba M; Masuda T; Nakamura T; Horimasu Y; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Intern Med; 2017 Dec; 56(24):3327-3331. PubMed ID: 29021448
[TBL] [Abstract][Full Text] [Related]
3. Octreotide as therapeutic option for congenital idiopathic chylothorax: a case series.
Shah D; Sinn JK
Acta Paediatr; 2012 Apr; 101(4):e151-5. PubMed ID: 22092874
[TBL] [Abstract][Full Text] [Related]
4. Use of octreotide in the treatment of chylothorax and chyloperitoneum.
Pessotti CF; Jatene IB; Buononato PE; Elias PF; Pinto AC; Kok MF
Arq Bras Cardiol; 2011 Aug; 97(2):e33-6. PubMed ID: 22002034
[TBL] [Abstract][Full Text] [Related]
5. Use of Propranolol in the Treatment of Chylous Effusions in Infants.
Mitchell K; Weiner A; Ramsay P; Sahni M
Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34187907
[TBL] [Abstract][Full Text] [Related]
6. Octreotide for the treatment of chylothorax in neonates.
Das A; Shah PS
Cochrane Database Syst Rev; 2010 Sep; (9):CD006388. PubMed ID: 20824848
[TBL] [Abstract][Full Text] [Related]
7. Octreotide use in post-cardiac surgery chylothorax: a 12-year perspective.
Aljazairi AS; Bhuiyan TA; Alwadai AH; Almehizia RA
Asian Cardiovasc Thorac Ann; 2017 Jan; 25(1):6-12. PubMed ID: 27920229
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.
Roehr CC; Jung A; Proquitté H; Blankenstein O; Hammer H; Lakhoo K; Wauer RR
Intensive Care Med; 2006 May; 32(5):650-7. PubMed ID: 16532329
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous neonatal chylothorax treated with octreotide.
Siu SL; Lam DS
J Paediatr Child Health; 2006; 42(1-2):65-7. PubMed ID: 16487393
[TBL] [Abstract][Full Text] [Related]
10. Octreotide--additional conservative therapy for postoperative chylothorax in congenital heart disease.
Paramés F; Freitas I; Fragata J; Trigo C; Pinto MF
Rev Port Cardiol; 2009; 28(7-8):799-807. PubMed ID: 19894659
[TBL] [Abstract][Full Text] [Related]
11. Octreotide therapy for chylothorax in infants and children: A brief review.
Helin RD; Angeles ST; Bhat R
Pediatr Crit Care Med; 2006 Nov; 7(6):576-9. PubMed ID: 16878051
[TBL] [Abstract][Full Text] [Related]
12. Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax.
Yin R; Zhang R; Wang J; Yuan L; Hu L; Jiang S; Chen C; Cao Y
Medicine (Baltimore); 2017 Jul; 96(29):e7594. PubMed ID: 28723800
[TBL] [Abstract][Full Text] [Related]
13. Octreotide for congenital and acquired chylothorax in newborns: A systematic review.
Bellini C; Cabano R; De Angelis LC; Bellini T; Calevo MG; Gandullia P; Ramenghi LA
J Paediatr Child Health; 2018 Aug; 54(8):840-847. PubMed ID: 29602276
[TBL] [Abstract][Full Text] [Related]
14. Octreotide therapy for chylous ascites in a chronic dialysis patient.
Lee PH; Lin CL; Lai PC; Yang CW
Nephrology (Carlton); 2005 Aug; 10(4):344-7. PubMed ID: 16109079
[TBL] [Abstract][Full Text] [Related]
15. Octreotide for chylous effusions in congenital diaphragmatic hernia.
Landis MW; Butler D; Lim FY; Keswani S; Frischer J; Haberman B; Kingma PS
J Pediatr Surg; 2013 Nov; 48(11):2226-9. PubMed ID: 24210190
[TBL] [Abstract][Full Text] [Related]
16. Postoperative chylous ascites in a neonate treated successfully with octreotide: bile sludge and cholestasis.
Andreou A; Papouli M; Papavasiliou V; Badouraki M
Am J Perinatol; 2005 Nov; 22(8):401-4. PubMed ID: 16283598
[TBL] [Abstract][Full Text] [Related]
17. Chylous ascites after a living-donor liver graft, effectively treated in a child with octreotide.
Ünlüsoy Aksu A; Demirtaş Z; Eğritaş Gürkan Ö; Dalgıç B; Sözen H; Dalgıç A
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():173-4. PubMed ID: 24635821
[TBL] [Abstract][Full Text] [Related]
18. The use of high dose octreotide in management of neonatal chylothorax: Review.
Alhasoon MA
J Neonatal Perinatal Med; 2021; 14(4):457-461. PubMed ID: 33843702
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report.
Sivasli E; Dogru D; Aslan AT; Yurdakok M; Tekinalp G
J Perinatol; 2004 Apr; 24(4):261-2. PubMed ID: 15067298
[TBL] [Abstract][Full Text] [Related]
20. Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective study.
Bellini C; Ergaz Z; Radicioni M; Forner-Cordero I; Witte M; Perotti G; Figar T; Tubaldi L; Camerini P; Bar-Oz B; Yatsiv I; Arad I; Traverso F; Bellini T; Boccardo F; Campisi C; Dalmonte P; Vercellino N; Manikanti S; Bonioli E
Lymphology; 2012 Sep; 45(3):91-102. PubMed ID: 23342929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
